Critical Market Drivers Shaping the Outlook for Biologics Contract Development Market from 2025-2034: Surge In Chronic Diseases Drives Demand, Fueling Growth In The Biologics Contract Development Market
Discover trends, market shifts, and competitive outlooks for the biologics contract development industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Biologics Contract Development Market In 2029?
The market for biologics contract development has seen fast growth in the past few years. The market size is expected to expand from $7.75 billion in 2024 to $8.58 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.6%. Factors contributing to the notable growth during the historical period include the expansion of the biologics market, increase in biopharmaceuticals, the complexity of biologics, expiry of patents, and cost efficiency.
The market for contract development in biologics is predicted to experience a swift expansion in the coming years, projected to reach $13.19 billion by 2029, showing an 11.4% compound annual growth rate (CAGR). The projected surge during the forecast period can be linked to factors such as digitalization and data analytics, risk control measures, adaptable and scalable solutions, booming investments in research and development, as well as advancements in precision medicine and customized treatments. Key trends expected to arise during the forecast period involve regenerative medicine, strategies for risk reduction, global alliances, cutting-edge technology, and the consolidation of technology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp
What Are the Core Growth Drivers Propelling the Biologics Contract Development Market Forward?
The escalating occurrence of long-term diseases is anticipated to accelerate the progress of the biologics contract development market. Chronic diseases are defined as conditions that persist for over a year, necessitating continuous medical care. The surge in cases of these diseases is heightening the need for the creation of innovative drugs, such as biologics, which in turn bolsters the biologics contract development market. For example, data from the Office for Health Improvement & Disparities, a government entity in the UK, revealed that in the initial six months of 2023, a surplus of 3,940 deaths were associated with persistent lower respiratory diseases. This represents a 30% spike compared to anticipated rates. Over the full year, this figure swelled to 5,363, demonstrating an overall 22% rise. Consequently, the growing incidence of chronic diseases is expected to serve as a catalyst for the expansion of the biologics contract development market.
What Segment Types Define the Biologics Contract Development Market Structure?
The biologics contract development market covered in this report is segmented –
1) By Source: Microbial, Mammalian, Others Sources
2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others Indications
3) By Product Service: Cell Line Development, Process Development, Others Product Services
Subsegments:
1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells
3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8219&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Biologics Contract Development Market?
North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theBiologics Contract Development Industry Evolution?
Biologics contract development market is experiencing an increase in popularity due to technological advancements. Main players in this market are leveraging cutting-edge technologies to maintain their market position. As an example, Lonza, a Swiss-based contract manufacturing and development solutions company, introduced the bYlok technology platform to create and produce bispecific antibodies in January 2022. This platform addresses the issue of light-heavy chain mispairing with greater than 95% accuracy, high yields and the capability to keep a mAb-like format. It is available to pharma and biotech firms via a straightforward research license.
View the full report here:
What Is the Definition of the Biologics Contract Development Market?
Biologics contract development refers to companies that provide biologics development and manufacturing services to pharmaceutical corporations on a contract basis. The biologics contract development is used to outsource the manufacturing of biologics on contracts to focus on the marketing, R&D, and branding of products.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8219
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
